MedTrace Logo

Cervical Carcinoma in Shatby University Hospital and Its Relation to Human Papilloma Virus

NCT05539274 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 70

Last updated 2022-10-03

No results posted yet for this study

Summary

incidence of detection of carcinogenic types of human papilloma virus in 60 cases of cervical cancer

Conditions

Interventions

DIAGNOSTIC_TEST

human papilloma virus testing and genotyping in cervical cancer cases

an observational analytical prospective cross-sectional study was managed from July 2019 to July 2022 on 70 cervical cancer patients collected from gyne-oncology unit in Shatby obstetrics and gynecology university hospital of Alexandria medical school after taking a written consent and following approval by Alexandria medical school institutional ethics committee. All patients were subjected to full history taking as age, gravidity, parity, contraceptive history, medical disease, detailed marital history and smoking. Collection of the sample from all cases of the study for human papilloma virus testing and genotyping was done after diagnostic workup and before treatment of the study cases at any time in post-menopausal women and at mid cycles period in premenopausal women by cervical smear using PAP spatula and endocervical brush.

Sponsors & Collaborators

  • Hossam Hassan Aly Hassan El Sokkary

    lead OTHER

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-07-01
Primary Completion
2022-06-01
Completion
2022-07-31

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05539274 on ClinicalTrials.gov